| ISSN No. : | 2471-9552 |
| Journal Title : | Immunotherapy: Open Access |
| Journal URL : | https://www.longdom.org/immunotherapy.html |
| Publisher Name : | Charles J. Malemud |
| Country : | Belgium |
| Language : | English |
| Discipline : | Interdiciplinary |
| Organization Name : | Longdom |
| Frequency : | Bi-monthly |
| Start Year : | 2015 |
| Journal Description : | NLM ID:101676003
Immunotherapy is a treatment procedure which enhances or supress the body’s immune system to fight against a disease. Immunotherapies which enhance the immune response are called as activation immunotherapies and those which reduce or suppress the immune response are called as suppression immunotherapies. Immunotherapy is of many types but the major immunotherapies for cancer include Monoclonal antibodies, Cancer vaccines and Non-specific immunotherapies.
The Journal of immunotherapy covers a wide range of topics related to allergy immunotherapy, cancer immunotherapy, immunotherapy for Kidney failure, lung cancer immunotherapy, melanoma immunotherapy, prostate cancer immunotherapy, sublingual immunotherapy, immunotherapy for HIV, immunotherapy for autoimmune diseases and transplantation, biomarkers for cancer immunotherapy, drug delivery systems and drug interactions, novel immunotherapeutic agents and immunotherapeutics clinical trials for immunotherapy etc. The journal also covers immunotherapeutic products, regulatory and FDI guidelines for immunotherapeutics and immunotherapy for kidney failure.
The journal of immunotherapy accepts all types of articles including research, review, case reports, commentaries, hypotheses, meeting reports, editorials and short reports.
Journal of immunotherapy is using Editorial Tracking System for quality in review process. It is an online manuscript submission, review and tracking system used by most of the best open access journals. Review processing is performed by the editorial board members of Journal or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript. |
| Licence Type : | CC BY |